Bioelectronic medicine is a new approach to treating and diagnosing disease and injury that has emerged from the Feinstein Institutes' labs. It represents a convergence of molecular medicine, neuroscience and bioengineering. Bioelectronic medicine uses device technology to read and modulate the electrical activity within the body’s nervous system, opening new doors to real-time diagnostics and treatment options for patients.
We work to generate knowledge of the mechanisms of organ control by tapping into neural pathways, develop technology that delivers safe and effective therapies with fewer adverse effects, and rapidly advance our knowledge into clinical practice along a streamlined medical device regulatory pathway.
Our two primary discoveries are first, that inflammation is the central phenomenon in virtually all disease, from cancer to diabetes, and second, inflammation can be controlled through the vagus nerve, the body’s main “highway” of neural information that prompts and curbs inflammation. The institute's work in molecular biology to fully understand the vagus system and other nerve networks has led to a means to both monitor the neural signals produced by the body and decode them, not only to control inflammation, but to anticipate incipient disease before it takes hold.
One of the exciting aspects of bioelectronic medicine is its potential to supplement and even replace drugs, including their cost and often debilitating side effects.
Presented by
Visit Home Page
Replacing Drugs and Limiting Side Effects
Through Medical Science and Technology
Institute of Bioelectronic Medicine
Watch Feinstein Institutes CEO Kevin J. Tracey’s TEDMED Talk
Dr. Tracey explains the discovery of the inflammatory reflex and the crucial insight that curbing inflammation is critical to beating most disease. He reveals how the vagus nerve acts as a superhighway of information throughout the body and can be influenced to regulate inflammation.
Click Here to Watch
Bioelectronic medicine may change the way we treat diseases, injuries and conditions such as rheumatoid arthritis, Crohn’s disease, diabetes, paralysis, bleeding, and even cancer. We are working to develop devices to control the electrical signal used by the nervous system.
The Fusion of Medicine and Technology
Click Here to Watch
CONTINUED LEARNING
Click Here to Watch
Click Here to Watch
More From This Series
Can Better Data Help Defeat the Next Pandemic?
Health care providers are already examining the lessons learned to begin preparing for the next pandemic.
Cooperation and Truth Matter – Especially During a Pandemic
Gain insight into the successful, coordinated emergency response to COVID-19.
Wearing a Mask is an Act of Kindness and a Life Saving Act
Please join Michael Dowling, CEO of Northwell Health, in showing your community that you care.
Visit Home Page
Presented by
Scientists are using bioelectronic medicine to treat inflammatory diseases, an approach that capitalizes on the ancient "hardwiring" of the nervous system.
Click Here to Read
Click Here to Read
How tiny bioelectronic implants may someday replace pharmaceutical drugs
To learn more about the global scientific home of bioelectronic medicine, the Feinstein Institutes, click here.
Excerpt from Health Care Reboot on Bioelectronic Medicine
"...In some cases [drugs] cost tens of thousands of dollars per year are not effective in all patients and may carry “black-box warnings, which means that death is a possible side effect.” Why would patients pursue a drug regimen when they could opt for a few electronic pulses? Is it possible that treatments like this, pulses through electronic devices, could replace some drugs in the coming years as preferred treatments? Tracey believes it is, and that is perhaps why the pharmaceutical industry closely follows his work.
“The potential of this is so staggering,” says Dr. Lawrence Smith. “I don’t think anyone knows yet how far this can go.”
VIEW BOOK ONLINE
“Medical Advances: Miracles of Science.” Health Care Reboot: Megatrends Energizing American Medicine, by Michael J. Dowling and Charles Kenney, Forbes Books, 2018, pp. 62–65.
Bioelectronic medicine is a new approach to treating and diagnosing disease and injury that has emerged from the Feinstein Institutes' labs. It represents a convergence of molecular medicine, neuroscience and bioengineering. Bioelectronic medicine uses device technology to read and modulate the electrical activity within the body’s nervous system, opening new doors to real-time diagnostics and treatment options for patients.
We work to generate knowledge of the mechanisms of organ control by tapping into neural pathways, develop technology that delivers safe and effective therapies with fewer adverse effects, and rapidly advance our knowledge into clinical practice along a streamlined medical device regulatory pathway.
Dr. Tracey explains the discovery of the inflammatory reflex and the crucial insight that curbing inflammation is critical to beating most disease. He
reveals how the vagus nerve acts as a superhighway of information throughout the body and can be influenced to regulate inflammation.
Watch Feinstein Institutes CEO Kevin J. Tracey’s TEDMED Talk
Scientists are using bioelectronic medicine to treat inflammatory diseases, an approach that capitalizes on the ancient "hardwiring" of the nervous system.
How tiny bioelectronic implants may someday replace pharmaceutical drugs